UNSPSC 51294909: Dosulepin hydrochloride

This classification denotes an antidepressant agent with the molecular formula C19H21NS.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3H0042311V, chemically known as 11-(3-dimethylaminopropylidene)-6,11-dihydrodibenzo(b,e)thiepine hydrochloride but more generally known as dosulepin hydrochloride, which bears US NIH Compound Identifier 5282425. European Medicines Agency schedules Dosulepin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01821MIG.

Most nations, for tariff and trade purposes, schedule dosulepin hydrochloride under HS 29349990 and SITC 51579. SMILES: CN(C)CC/C=C/1\C2CCCCC2CSC3C1CCCC3.CL.

UNSPSC 51294909 Dosulepin hydrochloride is a Commodity code that in recent state and local procurement activity reflects misalignment between the code's pharmaceutical taxonomy designation and actual buying patterns. The single recent opportunity shows that while the code nominally denotes a specific antidepressant medication, state and local bodies are using it to procure naloxone (an opioid antagonist) and drug deactivation systems—product lines unrelated to dosulepin's therapeutic class. State and local health departments and county-level public health agencies appear to be the primary issuing bodies, though the recent record is too thin to establish a reliable pattern of repeat buyers or jurisdictional concentration.

Seminole County, Florida posted the sole recent opportunity under this code: IFB 60459723LAS, issued June 30, 2026, with a response deadline of July 26, 2023 (note: the posted date and response deadline show inconsistent years in the source). The county sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors must include shipping and delivery costs in their bids, hold E-Verify certification, maintain specified insurance coverage, and accept a three-month probationary termination clause. The contract carries an initial two-year term with a one-year renewal option and potential FEMA funding, introducing federal compliance overlay including Clean Air Act and Federal Water Pollution Control Act adherence. The code shows minimal recent activity and poor alignment with its nominal scope; pursuit would require confirmation that dosulepin procurement opportunities exist elsewhere in state and local markets, as current records suggest this code misclassifies the public health commodities actually being bought.